• 한국콘텐츠학회논문지
• /
• 제22권7호
• /
• pp.652-662
• /
• 2022

현재 전 세계 의료계의 척추 수술 영역에선 다양한 신기술들이 빠르게 개발되어 임상에 적용되어 오고 있다. 논자는 이러한 신기술들이 환자에게 시술되기 전에 효능과 안전성에 대한 검토가 충실하게 이루어지고 있는지 논의해 볼 필요가 있다고 생각한다. 논자는 이 주제를 고찰하기 위해, 2000년대에 추간판성 통증 질환 치료의 신기술로 등장하여 현재까지 전 세계적으로 널리 시술되어오고 있는 추간판 내열 치료술의 기초 연구 자료들과 임상 적용 과정을 분석하였다. 그 결과 이 시술은 효능과 안전성에 관한 기반 연구가 불충분한 상태에서 임상 적용해 온 것으로 평가되었다. 논자는 이 사례가 현재 척추 수술 영역 신의료기술들의 임상 적용과 관련한 본질적 문제를 드러내고 있다고 판단한다. 따라서 논자는 척추 수술 영역의 신의료기술이 환자들에게 미칠 수 있는 부작용을 최소화하기 위해선 보다 충실한 수준의 기초 연구와 보다 높은 수준의 임상 허용기준이 갖추어져야 한다고 생각한다.

• 방송과미디어
• /
• 제24권3호
• /
• pp.100-113
• /
• 2019

VR 기술 및 활용에 대한 다양한 연구와 장밋빛 전망에도 불구하고, 현재 우리 법 제도는 VR 산업 활성화의 걸림돌이 되는 규제들을 완전히 제거하지 못한 상태이다. 특히, 의료 및 게임 분야에서 VR 콘텐츠의 특수성을 고려한 맞춤형 규제설계가 필요하다. 먼저, 현행 규제상 의료용 VR 콘텐츠 및 소프트웨어는 의료기기 수입 제조허가와 신의료기술평가를 모두 거쳐야 하는데, 특히 신의료기술평가의 경우에는 의료용 VR 콘텐츠 및 소프트웨어에 대한 대비가 충분하지 않아 이의 활용에 상당한 장애가 될 수 있다. 그러므로 정부가 가이드라인 등 적절한 해석기준을 통해 의료기기의 범위를 불필요하게 확대하지 않도록 하고, 아울러 신의료기술평가에 있어 '선 진입, 후 평가' 제도를 활용할 수 있도록 개선이 요구된다. 다음으로, 게임의 경우에는 현행 게임산업법상 게임물의 정의가 너무 광범위하여 양방향성이 있는 VR 콘텐츠들이 게임물로 분류되어 불필요한 규제를 받을 가능성이 있으며, 여기에 더하여 최근 세계보건기구에서 '게임 이용 장애'를 국제질병분류에 포함시킴으로써 추가 규제에 대한 우려까지 더해지고 있다. 이러한 문제점을 해결하기 위해서는 법제처가 최근 발표한 "적극행정 법제 가이드라인"의 취지에 맞게 정부가 게임물 규제의 범위를 적극적으로 축소 해석하거나, 이러한 규제의 예외를 정하는 고시 또는 가이드라인을 제정할 필요가 있다. 또한, 현재 시행 중인 'ICT 규제 샌드박스' 제도를 잘 활용하고, 이와 별도로 국제질병분류의 국내 수용에 대해서도 보다 신중하게 접근할 필요가 있을 것이다.

• 헬스앤미션
• /
• 통권14호
• /
• pp.14-17
• /
• 2009

사람들은 인터넷을 통해 이메일, 커뮤니케이션, 쇼핑 등 다양한 활동을 즐기고 있다. 인터넷을 통해 의료정보를 접하게 되는 것도 이런 맥락에서 하나의 분야일 뿐이다. 이미 생활의 중요한 축이 되어버린 인터넷이 제공하는 정보 그 중에서도 의료 서비스나 신의료기술 등에 관련된 정보를 어떻게 활용하는 것이 좋을지 생각해 보자.

• 대한예방한의학회지
• /
• 제21권3호
• /
• pp.75-85
• /
• 2017

Objectives : The new health technology assessment (nHTA) involves evaluating the safety and efficacy of the new health technology under the Medical Services Act by the New Health Technology Assessment Project Division from 2007. The purpose of this study is to understand the status of applications and recent trends of the results, and suggest strategies for the development of new health technologies in Korean Medicine. Methods : We investigated and analyzed the results of evaluation of new health technology of whole conventional medical and the list of new health technologies in Korean Medicine provided by the New Health Technology Assessment Project Division from 2007 to 2016. Results : The number of applications for new health technology of Korean medicine was low as 41 items in the whole number of 2,013 items. The evaluation method of new health technologies in both, the whole medical and Korean medicine fields was the same, but the tendency in results was very different. Most of the new health technology items in Korean medicine were classified as existing technology (20 items), early stage technology (7 items), and Only 2 items were evaluated as research stage technology. Conclusions : In order to develop new health technology in the Korean medical field, we have made suggestions about the health technology assessment systems, R&D infrastructures, and corporation with conventional medicines.

• Korean Journal of Acupuncture
• /
• 제29권2호
• /
• pp.315-326
• /
• 2012

Objectives : The new health technology assessment system was introduced in April 2007. The purpose of new health technology assessment is assessing safety and efficacy in deciding a behavior of new health technology according to the Health Insurance Act. This study aims to understand the present status of new health technologies of Korean medicine. Methods : This research introduces new health technologies and their present status, and searches for a development direction for the new health technology of Korean medicine in the future. Results : Thirty seven cases(3%) of Korean medicine doctors who utilized new health technologies application were found. In the status about new health technologies application by technologies assortment, diagnostic test techniques were used more often than treatment skills. New medical technology that included korean medicine doctor as actual user was only one item, i.e. HCV antibody test. Conclusions : In order for the new health technology of korean medicine to settle down well, continuous interest and efforts of both government and medical community are necessary.

• Korean Journal of Acupuncture
• /
• 제29권2호
• /
• pp.327-342
• /
• 2012

Objectives : Nowadays, the assessment of new health technologies is gaining interest as an important issue for the safety of national health in the rapidly changing medical environment. The aim of this study is to understand how ignorant the korean medicine doctors are of new health technologies. Methods : The authors conducted a survey on the status of the ignorance of new health technologies in Korean medical doctors by e-mail. Results : Korean medical doctors' ignorance of new health technologies proved serious. The awareness of the law, however, was reached to some degree. The respondents answered that the present items of Korean Medicine listed in the medical care expenses by national health insurance system are too deficient to treat their patients effectively. Conclusions : It is strongly needed to try for more active registration of Korean medical new health technologies.

• 대한예방한의학회지
• /
• 제17권2호
• /
• pp.89-103
• /
• 2013

Objectives: This study was aimed to contribute to the establishment of base for the development of new health technology in Korean Medicine. Methods: Survey was performed with 200 samples obtained through stratified sampling from the list of members of Association of Korean Medicine. Results: For the question about the recognition of new health technology, 54.0% answered 'yes' and 45.0% answered 'no', For the question about whether using the therapy not listed in the medical care of national health insurance, 43.5% answered 'use', Conclusion: Doctors of Korean Medicine seem to want the enlargement of new health technology in the Korean Medicine.

• 대한한의학회지
• /
• 제38권1호
• /
• pp.21-33
• /
• 2017

Objectives: The purpose of this study is to present the needs for New Health Technology in Korean medicine field and suggest the strategy to raise the application and selection rate. Methods: In this study, we reviewed the application status of New Health Technology application from April 27, 2007 to June 30, 2016. And we analyzed the assessment methods, procedures, and failure factors through the two Research stage technologies reports in Korean medicine field. Results: In Korean medicine field, the application status of New Health Technology is very small as 2% of the whole applications. Moreover, 62.9% of the applied technology were either an existing technology or an early technology, so did not enter the assessment process. Two technologies categorized as Research stage technology also had failed to adopt New Health Technology because they were lacking evidences or need more research to prove effectiveness. Conclusions: In order to develop New Health Technology in Korean medicine, more efforts should be made to activate research that can prove the safety and effectiveness of medical technology, and to create a quantitative or qualitative basis for the results of the research. Also, it is necessary to increase researchers' awareness of New Health Technology. And the strategy to positively utilize the "Limited Approval" to promote clinical studies.

• 보건행정학회지
• /
• 제30권2호
• /
• pp.164-177
• /
• 2020

This study aims to compare the experience of selected countries in operating separate payment system for new healthcare technology and to find implications for price setting in Korea. We analyzed the related reports, papers, laws, regulations, and related agencies' online materials from five selected countries including the United States, Japan, Taiwan, Germany, and France. Each country has its own additional payment system for new technologies: transitional pass-through payment and new technology ambulatory payment classification for outpatient care and new technology add-on payment for inpatient care (USA), an extra payment for materials with new functions or new treatment (C1, C2; Japan), an additional payment system for new special treatment materials (Taiwan), a short-term extra funding for new diagnosis and treatment (NUB; Germany), and list of additional payments for new medical devices (France). The technology should be proven safe and effective in order to get approval for an additional payment. The price is determined by considering the actual cost of providing the technology and the cost of existing similar technologies listed in the benefits package. The revision cycle of the additional payment is 1 to 4 years. The cost or usage is monitored during that period and then integrated into the existing fee schedule or removed from the list. We conclude that it is important to set the explicit criteria to select services eligible for additional payment, to collect and analyze data to assess eligibility and to set the payment, to monitor the usage or cost, and to make follow-up measures in price setting for new health technologies in Korea.

• 대한의료기공학회지
• /
• 제19권1호
• /
• pp.139-154
• /
• 2019

Objective : The purpose of this study is to report the results and evaluation of I phase of the Gigong Academy, hosted by the Korean Academy of Medical Gi-Gong. Methods : The assessment and results were used in questionnaires. Conclusions : 1. Total 109 persons participated from 1-1 to 1-5 with an average of 21.8 person attending each session, which was a rather unsatisfactory level. 2. In the age group of participants, those in their 40s were mostly about 70 percent, and those in their 30s were very small, forming a vulnerable hierarchy that lacks a middle class. 3. The main purpose of the Academy participants was Gigong training, but the purpose of treatment and rest increased over the round of session. 4. The quality of the Academy's lectures, systems, and venues is highly positive, which can be said to be successful, but there is a need for publicity to increase participants, and more encouragement for the lifestyle of personal training and health care.